Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute (OSUCCC – James) shared on LinkedIn:
“On our Cancer-Free World Podcast, Daniel Stover, explains how his Ohio State team uses digital pathology, liquid biopsy and other high-tech tools to improve outcomes for today’s cancer patients while working in the lab to develop future oncology breakthroughs.
To which, Daniel Stover, Associate Professor of Medicine and the Director of Translational Breast Cancer Research at the Ohio State University Comprehensive Cancer Center, added:
“Had so much fun sharing the exciting work that the Stover Lab has been working on over the past 8+ years!
- Liquid biopsy testing studies supported by Pelotonia and Susan G. Komen – and now designing prospective clinical trials,
- Digital pathology work supported by donors, The Breast Cancer Research Foundation and now National Cancer Institute (NCI).
Thanks to Steve and Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute!”
You can also read ‘OSUCCC 2026 Research Summit‘
